Evaluation of the Uterine Cavity After Operative Hysteroscopy

NCT06924437 | Completed

• 1 other identifier: Soh-Med--25-3-05MS
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study will focus on evaluation of the uterine cavity after operative hysteroscopy using three dimensional transvaginal ultrasonography and office hysteroscopy to detect and residual or recurrent abnormalities or intrauterine adhesions to optimize the results of operative hysteroscopy in different uterine pathologies such as uterine polyps, fibroids, adhesions in addition to mullerian anomalies especially uterine septum .

Conditions

Infertility; Abnormal Uterine Bleeding (AUB); Intrauterine Adhesion; Submucous Leiomyoma of Uterus; Scar Niche; Uterine Septum; Endometrial Polyp

Outcome Measures

Primary Outcomes (1)

• Rate of bias in 3 dimensional ultrasonography compared to office hysteroscopy

  Comparing three dimensional ultrasonography and office hysteroscopy for uterine cavity evaluation after operative hysteroscopy as regards accuracy, pain score, and cost-effectiveness of each method.

  one year

Secondary Outcomes (1)

• Concentration of the risks and benefits between 3 dimensional ultrasonography and office hysteroscopy

  1 year

Other Outcomes (1)

• Number of participants with infertility , abnormal uterine bleeding and dysparunia

  1 year

Eligibility Criteria

• Age: 18 Years - 45 Years
• Gender Eligibility Details: Biological females
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

It will be held in the department of Obstetrics and Gynecology during the period from February 2025 to February 2026. The study will include all recruited patients who will be selected for operative hysteroscopy during that period.

You may qualify if:

• Patients in reproductive age group
• Patients already selected for operative hysteroscopy
• Patients accepted to share in the study
• Patients accepted to come for follow up ( within 3 months after the initial operative procedure, at least after 4 weeks

You may not qualify if:

• Patients outside the age of reproduction
• Patients with negative findings at operative hysteroscopy
• Patients refused to share in the study
• Patients not available for follow up
• Infection
• pregnancy or design of pregnancy

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Sohag university hospitals

Sohag, 82511, Egypt

Location

MeSH Terms

Conditions

Infertility; Metrorrhagia; Gynatresia; Septate Uterus

Condition Hierarchy (Ancestors)

Genital Diseases; Urogenital Diseases; Uterine Hemorrhage; Uterine Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Hemorrhage; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Uterine Duplication Anomalies

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident

Study Record Dates

• First Submitted: April 6, 2025
• First Posted: April 11, 2025
• Study Start: March 31, 2025
• Primary Completion: March 31, 2026
• Study Completion: June 8, 2026
• Last Updated: July 14, 2026

Record last verified: 2026-07

Locations

EG (1)